Copyright
©The Author(s) 2015.
World J Gastroenterol. Aug 28, 2015; 21(32): 9630-9637
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9630
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9630
Table 4 Prognostic factors predicting overall survival in propensity score-matched patients with solitary huge hepatocellular carcinoma undergoing hepatic resection or transarterial chemoembolization
Variable | Univariate analysis | Multivariate analysis | ||||
HR | 95%CI | P-value | HR | 95%CI | P-value | |
Age (yr) | 0.988 | 0.970-1.007 | 0.220 | |||
Gender (M/F) | 1.459 | 0.357-5.962 | 0.599 | |||
Tumor size (cm) | 1.054 | 0.973-1.141 | 0.197 | |||
HBsAg (+/-) | 1.391 | 0.340-5.685 | 0.646 | |||
Child-Pugh class (A/B) | 0.919 | 0.289-2.921 | 0.887 | |||
Cirrhosis (present/absent) | 1.207 | 0.621-1.611 | 0.579 | |||
AFP (≥ 400/< 400 ng/mL) | 1.721 | 1.097-2.347 | 0.018 | 1.997 | 1.259-3.166 | 0.003 |
Total bilirubin (μmol/L) | 1.025 | 0.994-1.057 | 0.116 | |||
ALT (U/L) | 1.004 | 1.000-1.009 | 0.052 | |||
AST (U/L) | 1.003 | 0.997-1.008 | 0.322 | |||
Prothrombin time (s) | 1.052 | 0.922-1.201 | 0.453 | |||
Albumin (g/L) | 1.010 | 0.969-1.053 | 0.653 | |||
Platelet count (109/L) | 0.998 | 0.995-1.001 | 0.190 | |||
Vascular invasion (present/absent) | 2.335 | 1.057-5.159 | 0.036 | 2.347 | 1.051-5.242 | 0.037 |
Treatment modality (TACE/hepatic resection) | 2.343 | 1.468-3.741 | < 0.001 | 2.492 | 1.550-4.006 | < 0.001 |
-
Citation: Zhu SL, Zhong JH, Ke Y, Ma L, You XM, Li LQ. Efficacy of hepatic resection
vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. World J Gastroenterol 2015; 21(32): 9630-9637 - URL: https://www.wjgnet.com/1007-9327/full/v21/i32/9630.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i32.9630